Luzsana Bio

Luzsana Biotechnology is a global biopharmaceutical company dedicated to developing and delivering high-quality, affordable medicines to patients worldwide. As a subsidiary of Hengrui Pharma, the company leverages a robust pipeline of innovative therapies across oncology, immunology, and other therapeutic areas. Luzsana focuses on bridging the gap between drug discovery and global patient access by conducting international clinical trials and pursuing regulatory approvals in major markets including the United States, Europe, and Japan. Their portfolio includes a diverse range of modalities such as small molecules, monoclonal antibodies, and antibody-drug conjugates.